Trends in participant race and sex reporting in lung cancer phase III clinical trials.

Faaiq N AslamRami ManochakianYanyan LouGerardo Colon-OteroTaimur Sher

Published in: Cancer reports (Hoboken, N.J.) (2023)

We found that the reporting and participation of minority races continue to lag that of other demographic factors like sex in phase III clinical trials in lung cancer. Based on our analysis, we note a decline in participation of African Americans in lung cancer phase III clinical trials despite the rising incidence of lung cancer.

Keyphrases

phase iii
clinical trial
open label
phase ii
double blind
placebo controlled
physical activity
risk factors
emergency department